Inventor · disambiguated record
Jose Baselga
Also filed as: BASELGA JOSE · BASELGA JOSE T
6 granted patents·8 pending applications·36 citations·filing 2003–2024
79Inventor score
Files withMEMORIAL SLOAN KETTERING CANCER CENTER9BAKER JOFFRE B2BASELGA JOSE1GENOMIC HEALTH INC1MASSACHUSETTS GEN HOSPITAL1
Top patents by PatentIndex Score
14 records- 0191US8148076B2Gene expression profiling of EGFR positive cancerBAKER JOFFRE B·Filed 2011·Granted Apr 3, 2012·10 cites·8 claims
- 0288US8008003B2Gene expression profiling of EGFR positive cancerGENOMIC HEALTH INC·Filed 2003·Granted Aug 30, 2011·23 cites·15 claims
- 0375US2025302841A1Use of phosphoinositide 3-kinase inhibitors for treatment of vascular malformationsMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2024·Application pending·0 cites
- 0473US2024350504A1Use of phosphoinositide 3-kinase inhibitors for treatment of vascular malformationsMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2023·Application pending·0 cites
- 0572US10864215B2Use of phosphoinositide 3-kinase inhibitors for treatment of vascular malformationsMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2017·Granted Dec 15, 2020·2 cites·9 claims
- 0672US2024100059A1Use of phosphoinositide 3-kinase inhibitors for treatment of vascular malformationsMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2023·Application pending·0 cites
- 0764US11248229B2Inhibition of KMT2D for the treatment of cancerMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2019·Granted Feb 15, 2022·0 cites·8 claims
- 0863US9566334B2Combinations of a PI3K/AKT inhibitor compound with an HER3/EGFR inhibitor compound and use thereof in the treatment of a hyperproliferative disorderMASSACHUSETTS GEN HOSPITAL·Filed 2013·Granted Feb 14, 2017·1 cites·8 claims
- 0961US2021060031A1Use of phosphoinositide 3-kinase inhibitors for treatment of vascular malformationsMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2020·Application pending·0 cites
- 1060US2022307031A1Inhibition of kmt2d for the treatment of cancerMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2022·Application pending·0 cites
- 1160US2012178644A1Gene expression profiling of egfr positive cancerBAKER JOFFRE B·Filed 2012·Application pending·0 cites
- 1247US2021189503A1Biomarkers for determining responsiveness of a cancer to pi3k inhibitorsMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2021·Application pending·0 cites
- 1342US11696924B2Combination therapy using PDK1 and PI3K inhibitorsMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2018·Granted Jul 11, 2023·0 cites·9 claims
- 1432US2012059005A1Combination of (a) a phosphoinositide 3-kinase inhibitor and (b) an antidiabetic compound for use in the treatment of proliferative diseasesBASELGA JOSE·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jose Baselga files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →